Atlas Trials

Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum

Clinical trial NCT05355467 · COMPLETED

Trial details

NCT number
NCT05355467
Sponsor
Mylan (Taiwan) Ltd
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis B Infection
Start date
2019-08-21
Primary completion
2021-07-13
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.